NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease

Slides:



Advertisements
Similar presentations
The Nod2 Sensor Promotes Intestinal Pathogen Eradication via the Chemokine CCL2- Dependent Recruitment of Inflammatory Monocytes Yun-Gi Kim, Nobuhiko Kamada,
Advertisements

Volume 31, Issue 3, Pages (September 2009)
The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response
Acute Graft-versus-Host Disease: Novel Biological Insights
Cytokines, Skin, and Smallpox–A New Link to an Antimicrobial Peptide
Pathogen-Mediated Posttranslational Modifications: A Re-emerging Field
Duane R. Wesemann, Cathryn R. Nagler  Immunity 
Immune Responses to the Microbiota at the Intestinal Mucosal Surface
Microbial Influences in Inflammatory Bowel Diseases
Gut Microbiota: Mining for Therapeutic Potential
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Volume 139, Issue 5, Pages (November 2010)
Autophagy Meets Phagocytosis
Antimicrobial peptides
Tumor necrosis factor: Biology and therapeutic inhibitors
Volume 44, Issue 6, Pages (June 2016)
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
T Helper 17 Cells Get the NOD
Endosomes as Platforms for NOD-like Receptor Signaling
Reprint of: Acute Graft-versus-Host Disease: Novel Biological Insights
Dissecting a Hub for Immune Response: Modeling the Structure of MyD88
Pathogen Recognition and Innate Immunity
The Intestinal Immune System in Obesity and Insulin Resistance
Intracellular Pathogens and CD8+ Dendritic Cells: Dangerous Liaisons
Lung Homeostasis: Influence of Age, Microbes, and the Immune System
Figure 2 Pro-inflammatory and anti-inflammatory effects of the gut microbiota Figure 2 | Pro-inflammatory and anti-inflammatory effects of the gut microbiota.
Interleukin-17 Kick-Starts T Helper 1 Cell Differentiation
Heptose 1,7-Bisphosphate Directed TIFA Oligomerization: A Novel PAMP-Recognizing Signaling Platform in the Control of Bacterial Infections  Kumar Pachathundikandi,
The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial- Mesenchymal Barrier  Roni Nowarski, Ruaidhrí Jackson, Richard A. Flavell 
BTLA+ Dendritic Cells: The Regulatory T Cell Force Awakens
Alternative Activation of Macrophages: Mechanism and Functions
The Origins and Drivers of Insulin Resistance
Autophagy in the Pathogenesis of Disease
John G. Monroe, Mary E. Keir  Immunity 
Figure 1 Mucosal immune networks
Gabriel Mitchell, Ralph R. Isberg  Cell Host & Microbe 
Phagocytosis Immunity Volume 22, Issue 5, Pages (May 2005)
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Mechanisms of Disease: Inflammatory Bowel Diseases
Getting the Bugs out of the Immune System: Do Bacterial Microbiota “Fix” Intestinal T Cell Responses?  Janet Chow, Sarkis K. Mazmanian  Cell Host & Microbe 
Richard Daneman, Maria Rescigno  Immunity 
T Cells Are Smad’ly in Love with Galectin-9
Fabiola Osorio, Caetano Reis e Sousa  Immunity 
Maya Saleh, Charles O. Elson  Immunity 
Wenjun Ouyang, Jay K. Kolls, Yan Zheng  Immunity 
Role of the Microbiota in Immunity and Inflammation
Translating Inflammatory Bowel Disease Research into Clinical Medicine
The Role of TIM-4 in Food Allergy
Inflammasomes in Intestinal Inflammation and Cancer
Overview of structural and functional mechanisms by which enterovirulent bacteria cause diarrhea. Overview of structural and functional mechanisms by which.
The Fire Within: Microbes Inflame Tumors
Roles of Caspases in Necrotic Cell Death
Homeostasis and Inflammation in the Intestine
Wenjun Ouyang, Anne O’Garra  Immunity 
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Norovirus Regulation by Host and Microbe
Intrinsic Defense Mechanisms of the Intestinal Epithelium
Intracellular NOD-like Receptors in Host Defense and Disease
Antimicrobial Defense of the Intestine
Volume 44, Issue 6, Pages (June 2016)
The End and After: How Dying Cells Impact the Living Organism
NOD2 and Crohn’s Disease: Loss or Gain of Function?
Macrophages, Immunity, and Metabolic Disease
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Volume 31, Issue 3, Pages (September 2009)
Tumor necrosis factor: Biology and therapeutic inhibitors
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
Presentation transcript:

NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease Roberta Caruso, Neil Warner, Naohiro Inohara, Gabriel Núñez  Immunity  Volume 41, Issue 6, Pages 898-908 (December 2014) DOI: 10.1016/j.immuni.2014.12.010 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Potential Mechanisms for Bacterial Recognition by NOD1 and NOD2 NOD1 and NOD2 sense intracellular PGN fragments from bacteria. Host cells can internalize PGNs by multiple routes, such as (1) phagocytosis of bacteria and subsequent bacterial degradation, (2) uptake of PGN fragments from bacteria-derived extracellular OMVs, (3) transport across host membranes via channels, pore-forming molecules, or bacterial secretion systems, (4) endocytosis, or (5) from neighboring cells. Once inside the cell, NOD1 and NOD2 activation typically involves their relocalization to various intracellular locations, such as the plasma and endosomal membranes, via different adaptor molecules that are differentially expressed in host cells. For example, the activation of NOD2 by intracellular pathogens induces the formation of an autophagosome, which is mediated by ATG16L1. Immunity 2014 41, 898-908DOI: (10.1016/j.immuni.2014.12.010) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 NOD2 Signaling Pathways for Gene Activation NOD2 interacts directly with intracellular bacterial PGN fragments containing the MDP motif. Ligand recognition relieves intramolecular autoinhibitory interactions, leading to NOD oligomerization. Recruitment of the downstream serine/threonine kinase (S/T kinase) RIPK2 occurs through CARD-CARD interactions. Subsequent activation of the NF-κB and MAPK pathways results in the transcriptional upregulation of proinflammatory and host-defense genes. Multiple steps in the pathway are regulated either positively or negatively by posttranslational modifications, such as phosphorylation and pUb events. Multiple regulatory genes act to influence various steps in the pathway, often in a cell-type-dependent manner. LUBAC stands for linear pUb chain assembly complex. Immunity 2014 41, 898-908DOI: (10.1016/j.immuni.2014.12.010) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 NOD2 and CD NOD2 plays a crucial role in regulating intestinal homeostasis. By sensing microbiota-derived PGN fragments, NOD2 activates NF-κB, which in turn leads to the production of Paneth cell (PC) antimicrobial peptides (AMPs), which provide a barrier between the microorganisms and the epithelial layer. Activation of NOD2 in dendritic cells (DCs) leads to the production of interleukin-23 (IL-23), thus promoting an early mucosal T helper 17 (Th17) cell response that enhances barrier protection by inducing IL-22 and regenerating islet-derived protein IIIγ (REGIIIγ). NOD2 activation in stromal cells also promotes CCL2-mediated recruitment of inflammatory monocytes (Mo) to the intestine. Interaction between NOD2 and ATG16L1 promotes autophagosome formation in intestinal epithelial cells (IECs) and intraepithelial bacterial clearance. CD-associated NOD2 variants perturb many aspects of immune homeostasis, including reduced MDP sensing in both macrophages (Mac) and DCs, impaired antimicrobial responses in PCs, and altered autophagy, leading to defective barrier function and/or bacterial clearance. These alterations, along with the development of dysbiosis, could lead to enhanced mucosal adherence and translocation of bacteria. Other abbreviations are as follows: GC, goblet cell; IEL, intraepithelial lymphocyte; and N, neutrophil. Immunity 2014 41, 898-908DOI: (10.1016/j.immuni.2014.12.010) Copyright © 2014 Elsevier Inc. Terms and Conditions